Monitor for additional Form 4 filings in the next 30 days — if selling accelerates above 0.1% of market cap or includes the CEO/CFO, the signal strengthens. For now, the small dollar amount relative to XERS's $1.5B market cap makes this a neutral data point; the stock's recent strength and strong analyst coverage suggest no bearish read-through.
Price Chart
Executive Summary
Three Xeris Biopharma insiders (McCulloch, Hecht, Pieper) sold a combined $311K in open-market shares on September 1, 2026 at ~$8.49-$8.50 per share. While a cluster of C-suite selling is notable, the total value represents ~0.02% of the $1.5B market cap — well below the 0.1% materiality threshold — and the sales coincide with the stock near multi-year highs, suggesting routine portfolio diversification rather than a bearish signal. The company's 85% bullish analyst consensus and 100% T+20 win rate on prior reports temper the concern.
Key Financial Metrics
Key Facts
- Three executives — McCulloch, Hecht, Pieper — sold a total of $311,242 in open-market sales on September 1, 2026
- Sales executed at $8.49-$8.50 per share, near XERS's recent highs
- Total sales equal ~0.02% of the $1.5B market cap, well below the 0.1% materiality threshold
- All three sellers have 'See Remarks' titles — likely C-suite or senior operational roles
- XERS has 85% bullish analyst consensus (11 of 13 Buy/Strong Buy) and 100% T+20 win rate on prior reports
Financial Impact
Open-market sales of $311K represent ~0.02% of market cap
Risk Factors
- Sales could accelerate if insiders diversify further ahead of potential Q3 2026 earnings
- Stock at multi-year highs may invite profit-taking by other holders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-XERS-1788301306922 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $7.71 $7.78 | ▲ +0.91% | ▲ +1.56% | $9.08 (+17.77%) |
Sep 1, 2026 4w ago | Insider Cluster | $8.58 $7.67 | ▼ −10.61% | ▼ −9.65% | $9.08 (+5.83%) |
Aug 6, 2026 8w ago | 8-K | $7.36 $8.33 | ▲ +13.18% | ▲ +11.97% | $9.08 (+23.37%) |
Aug 4, 2026 8w ago | Insider Cluster | $8.19 $8.39 | ▲ +2.44% | ▲ +2.54% | $9.08 (+10.87%) |
Jul 7, 2026 12w ago | Insider Cluster | $8.94 $8.28 | ▲ +7.38% | ▲ +7.93% | $9.08 (−1.57%) |
Jul 2, 2026 13w ago | 3 | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jul 2, 2026 13w ago | Insider Cluster | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jun 30, 2026 13w ago | 8-K | $8.00 $8.94 | ▲ +11.75% | ▲ +11.49% | $9.08 (+13.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $6.79 $6.95 | ▲ +2.36% | ▲ +1.68% | $9.08 (+33.73%) |
Jun 5, 2026 16w ago | Insider Cluster | $6.24 $6.88 | ▲ +10.26% | ▲ +8.14% | $9.08 (+45.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access